{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T04:14:40Z","timestamp":1745381680913,"version":"3.40.4"},"reference-count":14,"publisher":"IOP Publishing","issue":"2","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/page\/copyright"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"funder":[{"name":"Ministry of Higher Education, Oman"}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["J. Radiol. Prot."],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The blood sampling required for the verification of dose delivered during radioactive iodine (<jats:sup>131<\/jats:sup>I) therapy is a source of radiation exposure for healthcare staff. This study aims to estimate staff exposures, using Monte Carlo modelling, as well as experimental measurements. The study further aimed to validate the models with staff exposure measurements and examine the impact of protective measures on the procedure. The clinical set-up of blood sampling post <jats:sup>131<\/jats:sup>I patient administration, within a dedicated <jats:sup>131<\/jats:sup>I ablation therapy suite, was modelled using EGSnrc Monte Carlo simulations (MCSs). The dose scoring regions representing deep dose (Hp(10)) and skin dose (Hp(0.07)) were estimated and validated with an experimental approach and clinical monitoring of staff members using electronic personal dosimeters. MCSs and experimental values did not show significant differences between the two approaches (<jats:italic>p<\/jats:italic> &gt; 0.05), with simulated values having lower uncertainties. It is demonstrated that the model is capable of being tailored to clinical scenarios at any centre. The simulations were corroborated with dosimetry data of blood sampling from 14 patients post administering 3.7 GBq <jats:sup>131<\/jats:sup>I, amounting to a total of 54 measurements from 14 staff members. With the employed protective shielding, none of the staff were exposed to a dose rate approaching the annual dose constraint of 0.3 mSv.yr<jats:sup>\u22121<\/jats:sup>. The experimental and MCS data show good agreement with the clinical data, demonstrating the advantages of MCS approaches for providing useful information for planning and carrying out risk assessments before implementing a new dosimetry practice.<\/jats:p>","DOI":"10.1088\/1361-6498\/adc8b3","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T22:47:52Z","timestamp":1743720472000},"page":"021503","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Occupational radiation exposure during blood sample collection post I-131 therapeutic administration in thyroid cancer patients"],"prefix":"10.1088","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8885-2856","authenticated-orcid":true,"given":"Amna","family":"Al Jabri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3715-5729","authenticated-orcid":true,"given":"Jennie","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8185-968X","authenticated-orcid":true,"given":"Se\u00e1n","family":"Cournane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Louise","family":"Healy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"266","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"jrpadc8b3bib1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF01731834","article-title":"Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid","volume":"23","author":"Barrington","year":"1996","journal-title":"Eur. J. Nucl. Med."},{"year":"2014","author":"IAEA, EC, FAO, IAEA, ILO, OECD\/NEA, PAHO, UNEP, WHO","key":"jrpadc8b3bib2"},{"key":"jrpadc8b3bib3","first-page":"2110","article-title":"Iodine-131 contamination from thyroid cancer patients","volume":"33","author":"Ibis","year":"1992","journal-title":"J. Nucl. Med."},{"key":"jrpadc8b3bib4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/00004032-198004000-00002","article-title":"Monitoring of iodine excretion and used materials of patients treated with 1\u2013131","volume":"38","author":"Nishisawa","year":"1980","journal-title":"Health Phys."},{"key":"jrpadc8b3bib5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"jrpadc8b3bib6","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00259-008-0761-x","article-title":"EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy","volume":"35","author":"Lassmann","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"jrpadc8b3bib7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1967\/s002449910081","article-title":"A study of the time of hospital discharge of differentiated thyroid cancer patients after receiving iodine-131 for thyroid remnant ablation treatment","volume":"16","author":"Azizmohammadi","year":"2013","journal-title":"Hell. J. Nucl. Med."},{"key":"jrpadc8b3bib8","first-page":"1402","article-title":"Radiation safety considerations for post-iodine-131 thyroid cancer therapy","volume":"33","author":"Culver","year":"1992","journal-title":"J. Nucl. Med."},{"key":"jrpadc8b3bib9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1089\/thy.2011.0017","article-title":"Radioactivity of blood samples taken from thyroidectomized thyroid carcinoma patients after therapy with 131I","volume":"21","author":"Larkin","year":"2011","journal-title":"Thyroid"},{"key":"jrpadc8b3bib10","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2967\/jnumed.108.052464","article-title":"131I effective half-life and dosimetry in thyroid cancer patients","volume":"49","author":"Remy","year":"2008","journal-title":"J. Nucl. Med."},{"key":"jrpadc8b3bib11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/MNM.0000000000000223","article-title":"Estimation of patient attenuation factor for iodine-131 based on direct dose rate measurements from radioiodine therapy patients","volume":"36","author":"Soliman","year":"2015","journal-title":"Nucl. Med. Commun."},{"article-title":"EGSnrc toolkit for Monte Carlo simulation of ionizing radiation transport","year":"2000","author":"Kawrakow","key":"jrpadc8b3bib12"},{"article-title":"Dosimetric concepts and calibration of instruments","year":"2001","author":"Dietze","key":"jrpadc8b3bib13"},{"key":"jrpadc8b3bib14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejmp.2018.02.003","article-title":"Radiation protection from external exposure to radionuclides: a Monte Carlo data handbook","volume":"46","author":"Amato","year":"2018","journal-title":"Phys. Med."}],"container-title":["Journal of Radiological Protection"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/adc8b3","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/adc8b3\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/adc8b3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/adc8b3\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/adc8b3\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/adc8b3\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/adc8b3\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/adc8b3\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T10:40:58Z","timestamp":1745318458000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/adc8b3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4,22]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1088\/1361-6498\/adc8b3","relation":{},"ISSN":["0952-4746","1361-6498"],"issn-type":[{"type":"print","value":"0952-4746"},{"type":"electronic","value":"1361-6498"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"Occupational radiation exposure during blood sample collection post I-131 therapeutic administration in thyroid cancer patients","name":"article_title","label":"Article Title"},{"value":"Journal of Radiological Protection","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2025 Society for Radiological Protection. Published on behalf of SRP by IOP Publishing Limited. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2025-02-06","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2025-04-03","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2025-04-22","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}